Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 09-2022 | |
| Sales | 18,467 | 30,676 | 12,685 | 6,783 | 0 |
| Gross Profit | 18,467 | 30,676 | 12,685 | 6,783 | N/A |
| Operating Expenses | 58,479 | 57,441 | 55,637 | 55,473 | 0 |
| Operating Income | -40,012 | -26,765 | -42,952 | -48,690 | N/A |
| Other Income | 3,030 | 2,488 | 2,219 | 1,973 | 0 |
| Pre-tax Income | -36,982 | -24,277 | -40,733 | -46,717 | 0 |
| Net Income Continuous | -36,982 | -24,277 | -40,733 | -46,717 | N/A |
| Net Income | $-36,982 | $-24,277 | $-40,733 | $-46,717 | $N/A |
| EPS Basic Total Ops | -0.68 | -0.45 | -0.75 | -0.85 | N/A |
| EPS Basic Continuous Ops | -0.68 | -0.45 | -0.75 | -0.85 | N/A |
| EPS Diluted Total Ops | -0.68 | -0.45 | -0.75 | -0.85 | N/A |
| EPS Diluted Continuous Ops | -0.68 | -0.45 | -0.75 | -0.85 | N/A |
| EBITDA(a) | $-38,273 | $-24,422 | $-40,590 | $-46,303 | $N/A |